MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MMP-10 is Increased in Early Stage Diabetic Kidney Disease and can be Reduced by Renin-Angiotensin System Blockade
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-08
DOI
10.1038/s41598-019-56856-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of the early molecular changes in the glomeruli of Cd151 −/− mice highlights induction of mindin and MMP-10
- (2017) Crystal Naudin et al. Scientific Reports
- An autopsy study suggests that diabetic nephropathy is underdiagnosed
- (2016) Celine Q.F. Klessens et al. KIDNEY INTERNATIONAL
- Silent diabetic nephropathy
- (2016) Samar M. Said et al. KIDNEY INTERNATIONAL
- Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
- (2015) Stijn A Peeters et al. Cardiovascular Diabetology
- Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease
- (2015) Esther Martinez-Aguilar et al. JOURNAL OF VASCULAR SURGERY
- Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells
- (2014) YAN-SONG GUO et al. Molecular Medicine Reports
- Laminin α2-Mediated Focal Adhesion Kinase Activation Triggers Alport Glomerular Pathogenesis
- (2014) Duane Delimont et al. PLoS One
- Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
- (2014) Kei Fukami et al. Diabetology & Metabolic Syndrome
- Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients
- (2013) Marta Toni et al. DIABETOLOGIA
- Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice
- (2013) Sathnur Pushpakumar et al. JOURNAL OF HYPERTENSION
- Renal Lesions Predict Progression of Diabetic Nephropathy in Type 1 Diabetes
- (2013) M. L. Caramori et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Blockade of Renin-Angiotensin System Attenuates Advanced Glycation End Products-Mediated Signaling Pathways
- (2011) Masashi Kamioka et al. Journal of Atherosclerosis and Thrombosis
- Urinary matrix metalloproteinase-8 and -9 activities in type 2 diabetic subjects: A marker of incipient diabetic nephropathy?
- (2010) Nynke J. van der Zijl et al. CLINICAL BIOCHEMISTRY
- Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease
- (2010) Blai Coll et al. KIDNEY INTERNATIONAL
- In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
- (2009) Bruce A. Perkins et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation